GenMark Diagnostics is a molecular diagnostics company focused on developing and commercializing its sensor detection technology. The Companyâ??s electrochemical technology enables the detection of up to 72 distinct biomarkers in a single sample. Its XT-8 System has received 510(k) clearance from the United States Food and Drug Administration (FDA) and is designed to support a range of molecular diagnostic tests with a compact workstation and self-contained, disposable test cartridges. Within 30 minutes of receipt of an amplified deoxyribonucleic acid (DNA) sample, its XT-8 System produces results. The XT-8 System supports up to 24 test cartridges, which can be run independently, and are targeted for hospitals and reference laboratories. The Company is also developing its next-generation platform, the AD-8 System, to integrate DNA amplification with its sensor detection technology to enable technicians to place a minimally prepared patient sample into its test cartridge.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of GenMark Diagnostics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. GenMark Diagnostics Inc market cap is $1.77B.
What is the 52-week high for GenMark Diagnostics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. GenMark Diagnostics Inc 52 week high is $24.25 as of September 15, 2025.
What is the 52-week low for GenMark Diagnostics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. GenMark Diagnostics Inc 52 week low is $8.47 as of September 15, 2025.
What is GenMark Diagnostics Inc stock price today?
GenMark Diagnostics Inc stock price today is $24.04.
What was GenMark Diagnostics Inc stock price yesterday?
GenMark Diagnostics Inc stock price yesterday was $24.04.
What is the PE ratio of GenMark Diagnostics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. GenMark Diagnostics Inc’s P/E ratio is -84.89.
What is the Price-to-Book ratio of GenMark Diagnostics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. GenMark Diagnostics Inc P/B ratio is 18.3647.
What is the 50-day moving average of GenMark Diagnostics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. GenMark Diagnostics Inc 50-day moving average is $22.12.